Wire Stories

Embassy REIT Announces Rs. 8,520 million Acquisition of a Marquee Office Asset in Bengaluru

Third-party acquisition fortifies Embassy REIT’s leadership in Bengaluru’s prime office market 100% occupied premium asset,…

Malaysia Digital Economy Corporation and Ant International Deepen Partnership to Accelerate Digitalisation of MSMEs Across Malaysia

KUALA LUMPUR, Malaysia--(BUSINESS WIRE)--The Malaysia Digital Economy Corporation (MDEC) and Ant International are strengthening their…

Kioxia and Google Collaborate to Boost Clean Energy Use in Japan

YOKKAICHI, Japan--(BUSINESS WIRE)--As part of its commitment towards a more sustainable future, Kioxia Corporation (“Kioxia”)…

Mitsubishi Electric to Launch Two New XB Series HVIGBT Modules

For highly efficient, reliable inverter systems in railcars and large industrial equipment TOKYO--(BUSINESS WIRE)--Mitsubishi Electric…

KIOXIA AiSAQ and Memory-Centric AI Innovations Enable AI-Based Automatic Image Recognition for Logistics Processes

Collaboration with Tsubakimoto Chain and EAGLYS Delivers High-Capacity Storage Solution for Faster Market Response and…

Murata Unveils World’s First 15nF/1.25kV C0G MLCC in 1210-inch Size

KYOTO, Japan--(BUSINESS WIRE)--#MLCC--Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) announces the launch and mass…

Realtime Robotics to Debut Resolver for the Japanese Market at iREX 2025

Visit iREX Booth W4-61 to Experience the Interactive Resolver Demo and See the Latest Product…

Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers

New and expanded facilities provide local expertise, advanced technologies and tailored support for biopharma innovators…

Azul Platform Core Enables Ausgrid to Eliminate Oracle Java Audit Risk and Cut License Costs by 80%

Australia’s largest electricity distributor strengthens cybersecurity and compliance while reducing Java vulnerabilities by 99% SUNNYVALE,…

Pre-filled Syringe Presentation of BYOOVIZ®, Samsung Bioepis’ Biosimilar to Lucentis (Ranibizumab), Gains European Approval

European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopts positive opinion…